Skip to main content
. 2020 Sep 7;36(7):497–511. doi: 10.1089/jop.2020.0014

FIG. 1.

FIG. 1.

Changes of Schirmer test (A), TBUT (B), keratoepitheliopathy (C), and symptom score (D) in the LE 0.5% and fluorometholone 0.1% groups.49 Group A, LE group; Group B, fluorometholone group, *P < 0.05 versus the baseline. From Jung et al.49 Reproduced without modification under the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium. LE, loteprednol etabonate; TBUT, tear film breakup time.